Generally, it is considered that AR is negatively correlated with neuroendocrine differentiation in prostate cancer [24–26], however, in recent years, several studies have found co-expression of AR and NE markers in prostate cancer patients [25, 27, 28], and Su et al. The gene discussed is AR; the disease is Familial prostate cancer.